Teleflex Incorporated (NYSE:TFX) Shares Acquired by LGT Capital Partners LTD.

LGT Capital Partners LTD. increased its stake in Teleflex Incorporated (NYSE:TFX - Free Report) by 4.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 231,685 shares of the medical technology company's stock after buying an additional 9,411 shares during the quarter. Teleflex makes up 2.0% of LGT Capital Partners LTD.'s holdings, making the stock its 18th biggest position. LGT Capital Partners LTD. owned about 0.50% of Teleflex worth $57,300,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Pathstone Holdings LLC increased its holdings in shares of Teleflex by 34.8% during the third quarter. Pathstone Holdings LLC now owns 8,700 shares of the medical technology company's stock worth $2,152,000 after purchasing an additional 2,245 shares during the period. Thrivent Financial for Lutherans lifted its position in shares of Teleflex by 21.3% during the 3rd quarter. Thrivent Financial for Lutherans now owns 21,303 shares of the medical technology company's stock valued at $5,269,000 after acquiring an additional 3,736 shares during the period. Mutual of America Capital Management LLC grew its holdings in shares of Teleflex by 137.4% during the 3rd quarter. Mutual of America Capital Management LLC now owns 14,128 shares of the medical technology company's stock worth $3,494,000 after purchasing an additional 8,176 shares in the last quarter. SRS Capital Advisors Inc. increased its position in shares of Teleflex by 0.3% in the third quarter. SRS Capital Advisors Inc. now owns 19,587 shares of the medical technology company's stock worth $4,844,000 after purchasing an additional 60 shares during the period. Finally, Natixis Advisors LLC lifted its position in Teleflex by 4.7% during the third quarter. Natixis Advisors LLC now owns 20,916 shares of the medical technology company's stock worth $5,173,000 after purchasing an additional 937 shares during the period. Institutional investors and hedge funds own 95.62% of the company's stock.

Teleflex Stock Performance

NYSE:TFX traded down $1.15 on Tuesday, hitting $193.28. The stock had a trading volume of 249,594 shares, compared to its average volume of 377,921. Teleflex Incorporated has a 52-week low of $189.93 and a 52-week high of $257.85. The stock has a market cap of $8.98 billion, a price-to-earnings ratio of 38.65, a price-to-earnings-growth ratio of 1.97 and a beta of 1.18. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The business's 50-day simple moving average is $229.33 and its two-hundred day simple moving average is $223.34.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, beating the consensus estimate of $3.38 by $0.11. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The business had revenue of $764.40 million for the quarter, compared to the consensus estimate of $768.68 million. During the same quarter in the previous year, the firm earned $3.64 earnings per share. The company's revenue for the quarter was up 2.4% on a year-over-year basis. As a group, research analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Friday, November 15th will be paid a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.70%. The ex-dividend date is Friday, November 15th. Teleflex's dividend payout ratio is currently 27.04%.

Analyst Ratings Changes

Several equities research analysts have weighed in on the company. Stephens raised their target price on Teleflex from $275.00 to $290.00 and gave the company an "overweight" rating in a report on Friday, August 2nd. Mizuho reduced their price objective on Teleflex from $275.00 to $250.00 and set a "neutral" rating on the stock in a research report on Friday, November 1st. Royal Bank of Canada cut their target price on shares of Teleflex from $275.00 to $245.00 and set an "outperform" rating on the stock in a research report on Friday, November 1st. StockNews.com raised shares of Teleflex from a "hold" rating to a "buy" rating in a research note on Tuesday, November 12th. Finally, Truist Financial restated a "hold" rating and issued a $227.00 price objective (down from $255.00) on shares of Teleflex in a report on Monday, November 4th. Three equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $259.25.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.